3/18/2015 12:13:13 PM - Gapped up today rebounding above its 50 DMA line. Endured distributional pressure and did not form a sound base since last noted in the 3/04/15 mid-day report with caution - "Reported Dec '14 earnings +257% on +168% sales revenues, the 3rd consecutive quarter with earnings above the +25% minimum guideline (C criteria) along with encouraging guidance, then blasted higher quickly getting extended from prior highs. Prior mid-day reports cautioned members - 'Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.'"
3/4/2015 11:58:24 AM - Rebounding toward its 52-week high today and making its 2nd consecutive mid-day report appearance. Reported Dec '14 earnings +257% on +168% sales revenues, the 3rd consecutive quarter with earnings above the +25% minimum guideline (C criteria) along with encouraging guidance, then blasted higher quickly getting extended from prior highs. Prior mid-day reports cautioned members - "Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead."
3/3/2015 12:21:01 PM - Gapped down today, abruptly retreating from its 52-week high. Following its report of strong Dec '14 earnings +257% on +168% sales revenues and encouraging guidance last week it blasted higher, quickly getting extended from prior highs. The 2/27/15 mid-day report cautioned members - "Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Found support well above its 200 DMA line and made gradual progress since noted with caution the 12/10/14 mid-day report - 'Reported earnings +80% on +62% sales revenues for the Sep '14 quarter, the 2nd quarter with earnings above the +25% minimum guideline (C criteria).'"
2/27/2015 12:11:17 PM - Gapped up on the prior session for a new 52-week high following its report of strong Dec '14 earnings +257% on +168% sales revenues and encouraging guidance. Quickly getting extended from prior highs. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Found support well above its 200 DMA line and made gradual progress since noted with caution the 12/10/14 mid-day report - "Reported earnings +80% on +62% sales revenues for the Sep '14 quarter, the 2nd quarter with earnings above the +25% minimum guideline (C criteria)."
2/26/2015 11:59:00 AM - Gapped up today for a new 52-week high following its report of strong Dec '14 earnings and encouraging guidance. Quickly getting extended from prior highs, it found support well above its 200 DMA line and made gradual progress since last noted with caution the 12/10/14 mid-day report - "Reported earnings +80% on +62% sales revenues for the Sep '14 quarter, the 2nd quarter with earnings above the +25% minimum guideline (C criteria)."
12/10/2014 12:51:11 PM - Tallying a 4th consecutive gain today on ever-increasing volume while consolidating above its 50 DMA line. Reported earnings +80% on +62% sales revenues for the Sep '14 quarter, the 2nd quarter with earnings above the +25% minimum guideline (C criteria).
12/9/2014 12:31:05 PM - Consolidating above its 50 DMA line. Reported earnings +80% on +62% sales revenues for the Sep '14 quarter, the 2nd quarter with earnings above the +25% minimum guideline (C criteria).
10/22/2014 12:08:57 PM - Reported earnings +79% on +96% sales revenues for the Jun '14 quarter but fundamental concerns remain. Tallying considerable volume-driven gap up gains this week while hitting new 52-week highs. Prior mid-day reports cautioned - "Reported earnings +23% on +23% sales revenues for the Mar '14 quarter and prior quarterly earnings increases were sub par. Found support at its 200 DMA line during its deep consolidation. Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system."
10/21/2014 12:19:35 PM - Reported earnings +79% on +96% sales revenues for the Jun '14 quarter but fundamental concerns remain. Gapped up today for a considerable volume-driven gain hitting a new 52-week high. Undercut its 50 DMA line during its consolidation then rebounded since last noted in the 8/07/14 mid-day report with caution - "Reported earnings +23% on +23% sales revenues for the Mar '14 quarter and prior quarterly earnings increases were sub par. Found support at its 200 DMA line during its deep consolidation. Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system."
8/7/2014 11:59:13 AM - Reported earnings +79% on +96% sales revenues for the Jun '14 quarter but fundamental concerns remain. Encountering distributional pressure after hitting a new 52-week high when last noted in the 8/05/14 mid-day report with caution - "Reported earnings +23% on +23% sales revenues for the Mar '14 quarter and prior quarterly earnings increases were sub par. Found support at its 200 DMA line during its deep consolidation. Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system."
8/5/2014 11:51:17 AM - Gapped up today hitting a new 52-week high. Reported earnings +23% on +23% sales revenues for the Mar '14 quarter and prior quarterly earnings increases were sub par. Found support at its 200 DMA line during its deep consolidation since noted with caution in the 2/27/14 mid-day report - "Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system.'"
7/14/2014 12:03:22 PM - Making its 3rd consecutive mid-day report appearance approaching its 52-week high. Reported earnings +23% on +23% sales revenues for the Mar '14 quarter and prior quarterly earnings increases were sub par. Found support at its 200 DMA line during its deep consolidation since noted with caution in the 2/27/14 mid-day report - "Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system.'"
7/11/2014 12:03:27 PM - Making its 2nd consecutive mid-day report appearance consolidating near its 52-week high. Reported earnings +23% on +23% sales revenues for the Mar '14 quarter and prior quarterly earnings increases were sub par. Found support at its 200 DMA line during its deep consolidation since noted with caution in the 2/27/14 mid-day report - "Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system.'"
7/10/2014 12:10:00 PM - Consolidating near its 52-week high. Reported earnings +23% on +23% sales revenues for the Mar '14 quarter and prior quarterly earnings increases were sub par. Found support at its 200 DMA line during its deep consolidation since noted with caution in the 2/27/14 mid-day report - "Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system.'"
7/1/2014 12:06:26 PM - Considerable gap up gain today for a new 52-week high. Reported earnings +23% on +23% sales revenues for the Mar '14 quarter and prior quarterly earnings increases were sub par. Found support at its 200 DMA line during its deep consolidation since noted with caution in the 2/27/14 mid-day report - "Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system.'"
5/9/2014 12:17:46 PM - Consolidating within striking distance of its 52-week high. Reported earnings +23% on +23% sales revenues for the Mar '14 quarter. Found support at its 200 DMA line during its deep consolidation since last noted with caution in the 2/27/14 mid-day report - "Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system.'"
2/27/2014 12:10:14 PM - Retreating from its 52-week high hit earlier this week after volume-driven gains. The 2/24/14 mid-day report cautioned members - "Undercut its 50 DMA line during its consolidation then rebounded since noted with caution in the 12/24/13 mid-day report - 'Reported earnings +7% on +18% sales revenues for the quarter ended September 30, 2013 versus the year ago period. Prior quarterly comparisons showed stronger sales revenues and earnings increases which were waning. Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system.'"
2/25/2014 12:05:59 PM - Hit a new 52-week high with a gap up on the prior session adding to a recent spurt of volume-driven gains. The 2/24/14 mid-day report cautioned members - "Undercut its 50 DMA line during its consolidation then rebounded since noted with caution in the 12/24/13 mid-day report - 'Reported earnings +7% on +18% sales revenues for the quarter ended September 30, 2013 versus the year ago period. Prior quarterly comparisons showed stronger sales revenues and earnings increases which were waning. Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system.'"
2/24/2014 12:09:19 PM - Hitting a new 52-week high with today's gap up gain adding to a recent spurt of volume-driven gains. Undercut its 50 DMA line during its consolidation then rebounded since last noted with caution in the 12/24/13 mid-day report - "Reported earnings +7% on +18% sales revenues for the quarter ended September 30, 2013 versus the year ago period. Prior quarterly comparisons showed stronger sales revenues and earnings increases which were waning. Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system."
12/24/2013 11:06:39 AM - Consolidating near its 52-week high and above its 50 DMA line. Noted with caution repeatedly in prior mid-day reports - "Reported earnings +7% on +18% sales revenues for the quarter ended September 30, 2013 versus the year ago period. Prior quarterly comparisons showed stronger sales revenues and earnings increases which were waning. Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system."
12/18/2013 12:12:02 PM - Endured distributional pressure while retreating from its 52-week high with volume-driven losses last week. Noted with caution in prior mid-day reports - "Reported earnings +7% on +18% sales revenues for the quarter ended September 30, 2013 versus the year ago period. Prior quarterly comparisons showed stronger sales revenues and earnings increases which were waning. Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system."
12/10/2013 12:25:20 PM - Pulling back from its 52-week high with today's 2nd consecutive volume-driven loss. Last noted with caution in the 11/18/13 mid-day report - "Reported earnings +7% on +18% sales revenues for the quarter ended September 30, 2013 versus the year ago period. Prior quarterly comparisons showed stronger sales revenues and earnings increases which were waning. Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system."
11/18/2013 12:13:34 PM - Hitting new 52-week highs with today's 2nd consecutive volume-driven gain. Reported earnings +7% on +18% sales revenues for the quarter ended September 30, 2013 versus the year ago period. Prior quarterly comparisons showed stronger sales revenues and earnings increases which were waning. Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system.
3/6/2012 11:56:33 AM - Undercut its 50 DMA line earlier, then rebounded above that short-term average. Reported earnings -78% on +77% sales revenues for the quarter ended December 31, 2011 versus the year ago period. Noted in prior mid-day reports -"Recent quarterly comparisons show strong sales revenues and earnings increases, however it does not have a strong annual earnings history (A criteria not satisfied) matching the models of past great winners identified using the fact-based investment system."
2/10/2012 11:55:05 AM - Hitting a new 52-week high today after recently wedging up without great volume conviction from a previously noted orderly flat base above its 50 DMA line. Noted in prior mid-day reports -"Recent quarterly comparisons show strong sales revenues and earnings increases, however it does not have a strong annual earnings history (A criteria not satisfied) matching the models of past great winners identified using the fact-based investment system."
1/25/2012 12:00:35 PM - Holding its ground and building an orderly flat base above its 50 DMA line. Noted in prior mid-day reports -"Recent quarterly comparisons show strong sales revenues and earnings increases, however it does not have a strong annual earnings history (A criteria not satisfied) matching the models of past great winners identified using the fact-based investment system."
1/3/2012 11:59:26 AM - Holding its ground after volume-driven gains helped it rise into new high territory following a recent re-test of support near its 50 DMA line. Noted in prior mid-day reports when this pharmaceuticals firm was hovering near its 52-week high -"Volume totals have been cooling while holding its ground stubbornly above prior highs after a spurt of volume-driven gains helped this low-priced stock clear a 4-week consolidation. Recent quarterly comparisons show strong sales revenues and earnings increases, however it does not have a strong annual earnings history (A criteria not satisfied) matching the models of past great winners identified using the fact-based investment system."
12/23/2011 12:11:59 PM - Volume-driven gains helped it rise into new high territory after finding support last week near its 50 DMA line. Noted in prior mid-day reports when this pharmaceuticals firm was hovering near its 52-week high -"Volume totals have been cooling while holding its ground stubbornly above prior highs after a spurt of volume-driven gains helped this low-priced stock clear a 4-week consolidation. Recent quarterly comparisons show strong sales revenues and earnings increases, however it does not have a strong annual earnings history (A criteria not satisfied) matching the models of past great winners identified using the fact-based investment system."
12/19/2011 12:22:58 PM - Reversed into the red after early gains today into new high territory. Found support last week after a pullback near its 50 DMA line. Noted in prior mid-day reports when this pharmaceuticals firm was hovering near its 52-week high -"Volume totals have been cooling while holding its ground stubbornly above prior highs after a spurt of volume-driven gains helped this low-priced stock clear a 4-week consolidation. Recent quarterly comparisons show strong sales revenues and earnings increases, however it does not have a strong annual earnings history (A criteria not satisfied) matching the models of past great winners identified using the fact-based investment system."
12/15/2011 12:31:56 PM - Rebounding today after a damaging loss on heavy volume on the prior session led to a pullback near its 50 DMA line. Last noted in the 12/09/11 mid-day report when this pharmaceuticals firm was hovering near its 52-week high -"Volume totals have been cooling while holding its ground stubbornly above prior highs after a spurt of volume-driven gains helped this low-priced stock clear a 4-week consolidation. Recent quarterly comparisons show strong sales revenues and earnings increases, however it does not have a strong annual earnings history (A criteria not satisfied) matching the models of past great winners identified using the fact-based investment system."
12/9/2011 12:30:21 PM - Since last noted in the 11/30/11 mid-day report this pharmaceuticals firm has been hovering near its 52-week high. Volume totals have been cooling while holding its ground stubbornly above prior highs after a spurt of volume-driven gains helped this low-priced stock clear a 4-week consolidation. Previously noted- "Recent quarterly comparisons show strong sales revenues and earnings increases, however it does not have a strong annual earnings history (A criteria not satisfied) matching the models of past great winners identified using the fact-based investment system."
11/30/2011 12:04:52 PM - This pharmaceuticals firm hit a new 52-week high today. The low-priced stock was noted after a 4-week consolidation the 11/29/11 mid-day report - "Recent quarterly comparisons show strong sales revenues and earnings increases, however it does not have a strong annual earnings history (A criteria not satisfied) matching the models of past great winners identified using the fact-based investment system."
11/29/2011 12:09:14 PM - This low-priced firm in the pharmaceuticals business is challenging its 52-week high today after a 4-week consolidation. Last noted in the 11/02/11 mid-day report - "Recent quarterly comparisons show strong sales revenues and earnings increases, however it does not have a strong annual earnings history (A criteria not satisfied) matching the models of past great winners identified using the fact-based investment system."
11/2/2011 12:25:02 PM - This low-priced firm in the pharmaceuticals business hit a new high on the prior session, rising from a 6-week "V" shaped consolidation. Recent quarterly comparisons show strong sales revenues and earnings increases, however it does not have a strong annual earnings history (A criteria not satisfied) matching the models of past great winners identified using the fact-based investment system.
4/15/2011 12:26:51 PM - This low-priced firm in the pharmaceuticals business has hit a new high today, rising from an orderly base. It does not have a strong quarterly and annual earnings history (C and A criteria not satisfied) and fails to match the models of past great winners identified using the fact-based investment system.